ScholarIQanswers from OpenAlex

New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases

PaperCitations, authors & open-access status

New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases is a paper indexed in ScholarIQ from OpenAlex.

How many citations does New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases have?

ScholarIQcitation count

New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases has 0 citations in the OpenAlex counts ScholarIQ stores.

When was New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases published?

ScholarIQyear

New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases has 2025 year in the ScholarIQ index.

What is the open-access status of New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases?

ScholarIQoa status

New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases has gold oa status in the ScholarIQ index.

What is the DOI of New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases?

ScholarIQdoi

The DOI for New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases is on the source record.

What is the PMID of New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases?

ScholarIQpmid

The PMID for New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases is on the source record.

What is the OpenAlex record for New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases?

ScholarIQopenalex

The OpenAlex for New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial